Skip to main content

9 July 2025

Last updated: Tuesday 8 July 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Why pharma is paying a premium for assets

Sunday 18 March 2018

Interviewee/Contributor

Tim Sturgeon and Martin Gouldstone

Organisation

Results Healthcare

Organisations

US National Cancer Institute
4SC AG
LifeSci Advisors
Shire Plc
Karus Therapeutics Ltd
AXA Framlington Biotech Fund
BB Biotech Ventures
IP Group
Index Ventures
Humabs BioMed SA

Interviewees and Contributers

Bruno Pagliara and Vittore Tamassia
Mark Rothera
Jane Morrison
Heinz Schwer
Ulrich Mahr
Nina Cihoric
John Foerster
Justin Duckworth
Rolf Günther
John Mayo

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Louise Peacock joins Aravax

Saturday 5 July 2025

Hans Menssen joins Priothera

Saturday 5 July 2025

Filippa Stenberg joins Mölnlycke Health Care

Saturday 5 July 2025

Commit Biologics appoints scientific advisory board

Saturday 5 July 2025

Cristina Csimma joins Asgard Therapeutics

Saturday 5 July 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form